Literature DB >> 19381817

Brain and optic chiasmal herniations into sella after cabergoline therapy of giant prolactinoma.

Dinesh Kumar Dhanwal1, Ashok Kumar Sharma.   

Abstract

Optic chiasmal herniation following dopamine agonist therapy is a rare complication in patients with giant prolactinomas. But there are a few case reports of brain and chiasmal herniation following medical therapy in such cases. We report a young man who developed secondary visual loss and seizures after 6 months of medical treatment with cabergoline for giant prolactinoma. Magnetic resonance imaging of hypothalamic pituitary region revealed optic chiasmal and frontal lobe herniation into sella. There was marginal improvement in his vision after cabergoline dose reduction. The present case report highlights frontal lobe herniation in conjunction with optic chiasmal herniation as a very rare complication of medical therapy of giant prolactinoma. Different treatment options of this condition are being discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19381817     DOI: 10.1007/s11102-009-0179-x

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  10 in total

1.  Brain & chiasmal herniations into sella after medical treatment of prolactinoma.

Authors:  M H Bangash; D B Clarke; R O Holness
Journal:  Can J Neurol Sci       Date:  2006-05       Impact factor: 2.104

2.  Herniation of the suprasellar visual system and third ventricle into empty sellae: morphologic and clinical considerations.

Authors:  B Kaufman; R L Tomsak; B A Kaufman; B U Arafah; E M Bellon; W R Selman; M T Modic
Journal:  AJR Am J Roentgenol       Date:  1989-03       Impact factor: 3.959

3.  Transsphenoidal treatment of empty sella by means of a silastic coil: technical note.

Authors:  Gianluigi Zona; Vincenzo Testa; Pier Filippo Sbaffi; Renato Spaziante
Journal:  Neurosurgery       Date:  2002-11       Impact factor: 4.654

4.  Endonasal endoscopic transsphenoidal chiasmapexy with silicone plates for empty sella syndrome: technical note.

Authors:  Shigeki Kubo; Hiroshi Hasegawa; Toshihiko Inui; Shinsuke Tominaga; Toshiki Yoshimine
Journal:  Neurol Med Chir (Tokyo)       Date:  2005-08       Impact factor: 1.742

Review 5.  Treatment of pituitary tumors: dopamine agonists.

Authors:  Gabriella Iván; Nikoletta Szigeti-Csúcs; Márk Oláh; György M Nagy; Miklós I Góth
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633

6.  Optic chiasmal herniation--an under recognized complication of dopamine agonist therapy for macroprolactinoma.

Authors:  S E Jones; R A James; K Hall; P Kendall-Taylor
Journal:  Clin Endocrinol (Oxf)       Date:  2000-10       Impact factor: 3.478

7.  Chiasmal herniation as a complication of bromocriptine therapy.

Authors:  P Taxel; D M Waitzman; J F Harrington; R H Fagan; N F Rothfield; H H Chen; C D Malchoff
Journal:  J Neuroophthalmol       Date:  1996-12       Impact factor: 3.042

8.  Secondary deterioration of visual field during cabergoline treatment for macroprolactinoma.

Authors:  Gérald Raverot; Maud Jacob; Emmanuel Jouanneau; Brigitte Delemer; Alain Vighetto; Michel Pugeat; Françoise Borson-Chazot
Journal:  Clin Endocrinol (Oxf)       Date:  2008-07-31       Impact factor: 3.478

9.  Delayed visual loss following pergolide treatment of a prolactinoma.

Authors:  Hideki Chuman; Wayne T Cornblath; Jonathan D Trobe; Stephen S Gebarski
Journal:  J Neuroophthalmol       Date:  2002-06       Impact factor: 3.042

10.  [Secondary empty sella syndrome: report of three cases and review of the literature].

Authors:  A Keyaki; Y Makita; S Nabeshima; M Motomochi; T Itagaki; T Tei
Journal:  No Shinkei Geka       Date:  1982-11
  10 in total
  8 in total

1.  Pons herniation into skull base after cabergoline therapy of giant prolactinoma.

Authors:  Jesús Moles Herbera; David Rivero Celada; Inmaculada Montejo Gañan; David Fustero de Miguel; Carlos Fuentes Uliaque; Ana Carmen Vela Marín
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

Review 2.  Non-compressive disorders of the chiasm.

Authors:  Valerie A Purvin; Aki Kawasaki
Journal:  Curr Neurol Neurosci Rep       Date:  2014-07       Impact factor: 5.081

Review 3.  Chiasmapexy for secondary empty sella syndrome: diagnostic and therapeutic considerations.

Authors:  Thomas Graillon; Thibault Passeri; Mohamed Boucekine; Mikael Meyer; Rosaria Abritti; Anne-Laure Bernat; Moujahed Labidi; Henry Dufour; Sébastien Froelich
Journal:  Pituitary       Date:  2020-11-02       Impact factor: 4.107

Review 4.  Treatment of empty sella associated with visual impairment: a systematic review of chiasmapexy techniques.

Authors:  Lina Raffaella Barzaghi; Carmine Antonio Donofrio; Pietro Panni; Marco Losa; Pietro Mortini
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

5.  Brain and Optic Chiasm Herniation into Sella after Pituitary Tumor Apoplexy.

Authors:  Maria M Pineyro; Patricia Furtenbach; Ramiro Lima; Saul Wajskopf; Nicolas Sgarbi; Raul Pisabarro
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-07       Impact factor: 5.555

6.  Empty Sella Syndrome as a Window Into the Neuroprotective Effects of Prolactin.

Authors:  David A Paul; Emma Strawderman; Alejandra Rodriguez; Ricky Hoang; Colleen L Schneider; Sam Haber; Benjamin L Chernoff; Ismat Shafiq; Zoë R Williams; G Edward Vates; Bradford Z Mahon
Journal:  Front Med (Lausanne)       Date:  2021-07-08

7.  General seizures revealing macro-adenomas secreting prolactin or prolactin and growth hormone in men.

Authors:  Farida Chentli; Lina Akkache; Katia Daffeur; Said Azzoug
Journal:  Indian J Endocrinol Metab       Date:  2014-05

8.  Chiasmal herniation following treatment of pituitary macroadenoma.

Authors:  Marjolein Tabak; Iris C M Pelsma; Mark C Kruit; Wouter R van Furth; Nienke R Biermasz; Irene C Notting
Journal:  Pituitary       Date:  2020-10-15       Impact factor: 4.107

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.